| For: | Kaewput W, Thongprayoon C, Dumancas CY, Kanduri SR, Kovvuru K, Kaewput C, Pattharanitima P, Petnak T, Lertjitbanjong P, Boonpheng B, Wijarnpreecha K, Zabala Genovez JL, Vallabhajosyula S, Jadlowiec CC, Qureshi F, Cheungpasitporn W. In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample. World J Gastroenterol 2021; 27(45): 7831-7843 [PMID: 34963745 DOI: 10.3748/wjg.v27.i45.7831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i45/7831.htm |
| Number | Citing Articles |
| 1 |
Sandeep Sikerwar, Sohrab Zand, Peter Steel, Arun Jesudian. Management of patients with cirrhosis in the emergency department: Implications for hospitalization outcomes. Liver Transplantation 2024; 30(1) doi: 10.1097/LVT.0000000000000285
|
| 2 |
J. Müller-Kühnle, M. Schanz, J. Latus, D. Marschner, S. Schricker. Life after hepatorenal syndrome: unraveling quality of life, psychological distress, and treatment preferences. BMC Palliative Care 2025; 24(1) doi: 10.1186/s12904-025-01871-7
|
| 3 |
Sandeep Sikerwar, Leah Yao, Yasmine Elfarra, Arun Jesudian. Optimal Management of the Inpatient With Decompensated Cirrhosis. Journal of Clinical Gastroenterology 2025; 59(5) doi: 10.1097/MCG.0000000000002143
|
| 4 |
Khoa Phuoc Nguyen, Xung Van Nguyen, Trung Hieu Doan. Impact of timing of endoscopy on clinical outcomes in cirrhotic patients with esophageal variceal bleeding: a monocentric retrospective study from Vietnam. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03989-7
|
| 5 |
Haley N. Johnson, Paul A. Juang. Evaluation of Terlipressin and In-Hospital Mortality in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI). Annals of Pharmacotherapy 2026; doi: 10.1177/10600280261467017
|
| 6 |
Aalam Sohal, Hunza Chaudhry, Dino Dukovic, Kris V. Kowdley. Outcomes among patients with hepatorenal syndrome based on hospital teaching and transplant status: Analysis of 159 845 hospitalizations. JGH Open 2023; 7(12) doi: 10.1002/jgh3.12985
|
| 7 |
Mohammad Aldiabat, Yazan Aljabiri, Mohannad H Al-Khateeb, Mubarak H Yusuf, Yassine Kilani, Ali Horoub, Fnu Farukhuddin, Ratib Mahfouz, Adham E Obeidat, Mohammad Darweesh, Mahmoud M Mansour. Effect of Hospital Teaching Status on Mortality and Procedural Complications of Percutaneous Paracentesis in the United States: A Four-Year Analysis of the National Inpatient Sample. Cureus 2022; doi: 10.7759/cureus.26282
|
| 8 |
Umer Farooq, Zahid Ijaz Tarar, Abdallah El Alayli, Faisal Kamal, Chengu Niu, Kamran Qureshi. Analyzing the utility of renal replacement therapy to manage hepatorenal syndrome in alcoholic hepatitis without liver transplantation: a nationwide analysis. Journal of Gastroenterology and Hepatology 2024; 39(3) doi: 10.1111/jgh.16388
|
| 9 |
Nipun Verma, Ashwani K. Singal. Editorial: The US burden of HRS‐AKI—Putting numbers to the problem: Authors' reply. Alimentary Pharmacology & Therapeutics 2023; 58(1) doi: 10.1111/apt.17562
|
| 10 |
Lorenzo Peluso, Marzia Savi, Giacomo Coppalini, Deliana Veliaj, Nicola Villari, Giovanni Albano, Stephen Petrou, Maria C. Pace, Marco Fiore. Management of hepatorenal syndrome and treatment-related adverse events. Current Medical Research and Opinion 2024; 40(7) doi: 10.1080/03007995.2024.2358242
|
| 11 |
Jeremy Skvarce, Albert Bui, Peter Oro, Saloni Sachar, Mary Pat Harnegie, Aanchal Kapoor, Christina C. Lindenmeyer, Matthew T. Siuba. Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review. Journal of Critical Care 2025; 87 doi: 10.1016/j.jcrc.2025.155038
|
| 12 |
Shaun Chandna, Mark R. Baniqued, Rhett Harmon, Patrick Chan, Jeffrey Wang, Jignesh H. Patel. Hepatorenal Syndrome in Focus. Journal of Clinical Gastroenterology 2026; 60(5) doi: 10.1097/MCG.0000000000002332
|
| 13 |
Noussa Mahmoud El-Adawy, Mahmoud Saad Abdel-Aleem, Roby Abdel-Aziz Abdel-Gelil, Zaki Mohamed Zaki, Hesham Kamal Habeeb Keryakos. Dual biomarker strategy with [TIMP-2]·[IGFBP7] and copeptin enhances early diagnosis and risk prediction in HRS-AKI. Nefrología 2026; 46(4) doi: 10.1016/j.nefro.2026.501486
|
| 14 |
Noussa Mahmoud El-Adawy, Mahmoud Saad Abdel-Aleem, Roby Abdel-Aziz Abdel-Gelil, Zaki Mohamed Zaki, Hesham Kamal Habeeb Keryakos. Dual biomarker strategy with [TIMP-2]·[IGFBP7] and copeptin enhances early diagnosis and risk prediction in HRS-AKI. Nefrología (English Edition) 2026; 46(4) doi: 10.1016/j.nefroe.2026.501486
|
| 15 |
Anupamaa Seshadri, Rachel Appelbaum, Samuel P Carmichael, Joseph Cuschieri, Jason Hoth, Krista L Kaups, Lisa Kodadek, Matthew E Kutcher, Abhijit Pathak, Joseph Rappold, Sean R Rudnick, Christopher P Michetti. Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. Trauma Surgery & Acute Care Open 2022; 7(1) doi: 10.1136/tsaco-2022-000936
|
| 16 |
Supawit Tangpanithandee, Charat Thongprayoon, Pajaree Krisanapan, Michael A. Mao, Wisit Kaewput, Pattharawin Pattharanitima, Boonphiphop Boonpheng, Wisit Cheungpasitporn. Distinct Subtypes of Hepatorenal Syndrome and Associated Outcomes as Identified by Machine Learning Consensus Clustering. Diseases 2023; 11(1) doi: 10.3390/diseases11010018
|
| 17 |
William M. Schmidt, Christopher B. Parker, Benjamin J. McCormick. 69-Year-Old Man With Acute Kidney Injury. Mayo Clinic Proceedings 2025; 100(6) doi: 10.1016/j.mayocp.2024.05.037
|
| 18 |
Osama Y. Alshogran, Shoroq M. Altawalbeh, Eman M. Almestarihi. Acute kidney injury development and impact on clinical and economic outcomes in patients with cirrhosis: an observational cohort study over a 10-year period. European Journal of Gastroenterology & Hepatology 2023; 35(4) doi: 10.1097/MEG.0000000000002520
|
| 19 |
Daniela Goyes, Basile Njei, Joseph K. Lim. Increasing Incidence, Cost, and Mortality of AKI and HRS in Hospitalized Patients With Cirrhosis. JAMA Network Open 2025; 8(5) doi: 10.1001/jamanetworkopen.2025.11822
|
| 20 |
Umer Farooq, Zahid I. Tarar, Ammad J. Chaudhary, Abdallah E. Alayli, Faisal Kamal, Chengdu Niu, Kamran Qureshi. Infection-Related Readmissions Are Rising among Patients with Hepatorenal Syndrome: A Nationwide Analysis. Livers 2024; 4(2) doi: 10.3390/livers4020019
|
| 21 |
Hatem Ahmed, Sameh Gomaa, Eyad Abdulrazzak, Imad Alabdul Razzak, Kellen K Kovalovich. Therapeutic Potential of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Liver Disease: Focus on Cirrhosis. Cureus 2025; doi: 10.7759/cureus.84768
|
| 22 |
Nivetha Saravanan, Daniel Ganger. Fast Facts and Concepts #536: Hepatorenal Syndrome—Acute Kidney Injury in End-Stage Liver Disease. Journal of Palliative Medicine 2026; doi: 10.1177/10966218261465475
|
| 23 |
Ashwani K. Singal, Yong‐Fang Kuo, K. Rajender Reddy, Ramon Bataller, Paul Kwo. Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis‐related hospitalisations in the US. Alimentary Pharmacology & Therapeutics 2022; 56(10) doi: 10.1111/apt.17232
|
| 24 |
Balaji Musunuri, Sandeep Gopal, Bailuru V. Tantry, Suresh Shenoy, Anurag J. Shetty. Predictors of Short-term Mortality in Patients of Cirrhosis of Liver Presenting as Acute Kidney Injury: An In-hospital Prospective Observational Study. Journal of Clinical and Experimental Hepatology 2023; 13(6) doi: 10.1016/j.jceh.2023.05.017
|
| 25 |
Syed Faisal Ali, Julia Natche, Mahendrakumar Achlaram Chaudhari, Hassan Abbasi, Sammy Dawoud, Hany Dawoud, Amna Shoaib, Hersh Tilokani, Harleen Kaur Chela, Arsal Zafar. Trends and Demographics of Hepatorenal Syndrome-Related Mortality in the U.S., 1999–2024: A CDC WONDER Analysis. Diseases 2026; 14(3) doi: 10.3390/diseases14030106
|